Match each patient's clinical profile with the most appropriate contraceptive method based on the World Health Organization Medical Eligibility Criteria (WHO MEC) and specific non-contraceptive benefits.
- A 24-year-old woman with a history of oligomenorrhea, severe acne, and bothersome facial hair growth who desires contraception.Combined oral contraceptive pills
- A 37-year-old woman who smokes a pack of cigarettes daily, has regular menses, and requests a long-acting, hormone-free contraceptive method.Copper intrauterine device
- A 31-year-old woman with a history of unprovoked deep vein thrombosis who currently experiences severe, heavy menstrual bleeding causing anemia.Levonorgestrel-releasing intrauterine device
- A 22-year-old woman with sickle cell disease experiencing frequent vaso-occlusive pain crises who struggles to remember taking daily medications.Depot medroxyprogesterone acetate
Cevap
The patient with hyperandrogenism matches with Combined oral contraceptive pills; the older smoker matches with the Copper intrauterine device; the patient with a prior DVT and heavy bleeding matches with the Levonorgestrel-releasing intrauterine device; and the patient with sickle cell disease matches with Depot medroxyprogesterone acetate.
Contraceptive selection must prioritize patient safety by avoiding methods with WHO MEC Category 4 contraindications (such as estrogen in women >35 who smoke or have a history of unprovoked thromboembolism) while leveraging the non-contraceptive benefits of specific methods (such as reduced sickling crises with DMPA, reduced bleeding with LNG-IUD, and reduced hyperandrogenism with COCs).
Adım Adım Çözüm
Anahtar Kavram
Selection of contraception based on Medical Eligibility Criteria (WHO MEC) and specific non-contraceptive benefits.
Tahmini Süre:1m 30s